CYP7A1 Monoclonal Antibody

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum membrane protein catalyzes the first reaction in the cholesterol catabolic pathway in the liver, which converts cholesterol to bile acids. This reaction is the rate limiting step and the major site of regulation of bile acid synthesis, which is the primary mechanism for the removal of cholesterol from the body. Polymorphisms in the promoter of this gene are associated with defects in bile acid synthesis.

Introducing the CYP7A1 Monoclonal Antibody, a highly specific and sensitive tool for the detection and quantification of CYP7A1 protein expression. This antibody has been rigorously tested and validated for use in a variety of applications, including Western blotting, immunohistochemistry, and ELISA.

The CYP7A1 Monoclonal Antibody is produced using state-of-the-art techniques and is of the highest quality, ensuring reliable and reproducible results. It recognizes a single epitope on the CYP7A1 protein, making it an ideal tool for studying the regulation and function of this important enzyme.

This antibody is supplied in a convenient format, with a range of sizes available to suit your specific needs. It is also accompanied by comprehensive technical support, including detailed protocols and troubleshooting advice, to ensure successful use in your experiments.

In summary, the CYP7A1 Monoclonal Antibody is a valuable tool for researchers studying the role of CYP7A1 in lipid metabolism and related diseases. Its high specificity and sensitivity, combined with its ease of use and comprehensive technical support, make it an excellent choice for a wide range of applications.